Ph. Eur. Reference Standard - LEAFLET

Size: px
Start display at page:

Download "Ph. Eur. Reference Standard - LEAFLET"

Transcription

1 European Directorate for the Quality of Medicines & HealthCare European Pharmacopoeia (Ph. Eur.), Allée Kastner CS 00, F-0 Strasbourg (France) Tel. + (0) 0 Fax. + (0) For any questions: (HelpDesk) Ph. Eur. Reference Standard - LEAFLET ACTAEA RACEMOSA HRS batch Intended use This leaflet supplements the currently valid European Pharmacopoeia monograph(s) and/or general chapter(s) describing the suitable use of this Reference Standard. Further information about the Reference Standards is available in the on-line catalogue currently at (such as, batch validity statement and material safety data sheet). Instruction For use with the monograph Black cohosh (0) *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

2 . Identification of Actaea racemosa. Monograph (Identification test C) Detection B: plate treatment as described in the monograph; daylight examination Requirement (Result B): see below the sequence of zones present in the chromatograms obtained with the reference solutions (a) and (b) and the test solution. Furthermore, other faint zones may be present in the chromatograms obtained with reference solution (a) and the test solution A brown zone (actein) A brown zone (-epi-deoxyactein) Actein: a brown zone A brown zone (actein) A brown zone (-epi--deoxyactein) - - A violet zone A violet zone A brown zone A violet zone A violet zone A brown zone Test solution. Example chromatograms Detection B: plate treatment as described in the monograph; daylight examination Track 0 Substance Isoferulic acid Norcimifugin Actein -epi- Deoxyactein Cimifugin Actaea racemosa HRS Actaea racemosa sample Cimicifuga foetida Cimicifuga heracleifolia Cimicifuga dahurica Cimicifuga americana 0 Corresponding reference solution *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

3 Detection C: plate treatment as described in the monograph (test for Adulteration with Cimicifuga americana Michx., C. foetida L., C. dahurica (Turcz.) Maxim. or C. heracleifolia Kom.), ultraviolet light at nm (for information only) 0 Note: This comparison of the different Cimicifuga species using detection C as described in the test on Adulteration with Cimicifuga americana Michx., C. foetida L., C. dahurica (Turcz.) Maxim. or C. heracleifolia Kom. may provide useful additional information when substitution of Actaea racemosa with C. americana, C. foetida, C. heracleifolia or C. dahurica is suspected.. Substitution by Cimicifuga americana Michx., C. foetida L., C. dahurica (Turcz.) Maxim. or C. heracleifolia Kom.. Monograph Detection A: ultraviolet light at nm Requirement (Results A): the chromatogram obtained with the test solution does not show any quenching zones more intense than those in the chromatogram obtained with reference solution (a) between RF value 0. and RF value 0... Example chromatograms 0 *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

4 Track 0 Substance Isoferulic acid Norcimifugin Actein -epi- Deoxyactein Cimifugin Actaea racemosa HRS Actaea racemosa sample Cimicifuga foetida Cimicifuga heracleifolia Cimicifuga dahurica Cimicifuga americana Corresponding reference solution. Adulteration with Cimicifuga americana Michx., C. foetida L., C. dahurica (Turcz.) Maxim. or C. heracleifolia Kom.. Presence of C. americana at a level higher than 0 per cent.. Monograph Detection (A): ultraviolet light at nm Requirement (Results A): the chromatogram obtained with the test solution does not show any quenching zone at RF value A weak zone weak zones A weak zone A weak zone A weak zone C. americana (0 per cent).. Example chromatograms Track : the arrow points to the zone indicating the presence of C. americana at a level higher than 0 per cent *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

5 Track Substance Corresponding reference solution actein Actaea racemosa HRS A. racemosa HRS containing % of C. heracleifolia A. racemosa HRS containing % of C. foetida A. racemosa HRS containing % of C. dahurica A. racemosa HRS containing 0% of C. americana A. racemosa HRS containing % of C. americana. Presence of C. foetida at a level higher than per cent.. Monograph Detection B: plate treatment as described in the monograph, ultraviolet light at nm Monograph requirement (Results B): the chromatogram obtained with the test solution does not show any intense fluorescent zone between R F value 0.0 and R F value 0.0 or at the same position as the intense fluorescent zone obtained with reference solution (c). Actein: a weak whitish zone Actein: a weak whitish zone Cimifugin: a bright fluorescent zone A weak whitish zone (actein) A bright fluorescent zone (cimifugin) A fluorescent zone Reference solution (c) C. foetida ( per cent).. Example chromatograms Track : the presence of one or both of the fluorescent zones marked by arrows indicates adulteration with C. Foetida at a level higher than per cent *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

6 Track Substance Corresponding reference solution actein Actaea racemosa HRS A. racemosa HRS containing % of C. heracleifolia A. racemosa HRS containing % of C. foetida A. racemosa HRS containing % of C. dahurica A. racemosa HRS containing 0% of C. americana A. racemosa HRS containing % of C. americana. Presence of C. heracleifolia and/or C. dahurica at a level higher than per cent.. Monograph Detection (C): plate treatment as described in the monograph, ultraviolet light at nm Monograph requirement (Results B): the chromatogram obtained with the test solution does not show any bright fluorescent zone just above the zone due to actein. A weak brownish zone (actein) Actein: a weak brownish zone A bright fluorescent zone Actein: a weak brownish zone C. heracleifolia ( per cent) or C. dahurica ( per cent).. Example chromatograms Track : the arrows point to the zone indicating the presence of C. heracleifolia at a level higher than per cent Track : the arrows point to the zone indicating the presence of C. dahurica at a level higher than per cent Track Substance Corresponding reference solution actein Actaea racemosa HRS A. racemosa HRS containing % of C. heracleifolia A. racemosa HRS containing % of C. foetida A. racemosa HRS containing % of C. dahurica A. racemosa HRS containing 0% of C. americana A. racemosa HRS containing % of C. americana *00Y0000.0* Catalogue code: Y000 Revision 0 Date of issue: /0/0 /

Ph. Eur. Reference Standard - LEAFLET

Ph. Eur. Reference Standard - LEAFLET European Directorate for the Quality of Medicines & HealthCare European Pharmacopoeia (Ph. Eur.) 7, Allée Kastner CS 30026, F-67081 Strasbourg (France) Tel. +33 (0)3 88 41 20 35 Fax. + 33 (0)3 88 41 27

More information

Ph. Eur. Reference Standard - LEAFLET

Ph. Eur. Reference Standard - LEAFLET European Directorate for the Quality of Medicines & HealthCare European Pharmacopoeia (Ph. Eur.) 7, Allée Kastner CS 30026, F-67081 Strasbourg (France) Tel. +33 (0)3 88 41 20 35 Fax. + 33 (0)3 88 41 27

More information

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS Aralia racemosa ad praeparationes homoeopathicas DEFINITION Dried, underground part of Aralia racemosa L.

More information

Black Cohosh Laboratory Guidance Document

Black Cohosh Laboratory Guidance Document Black Cohosh Laboratory Guidance Document By Stefan Gafner, PhD Chief Science Officer, American Botanical Council Technical Director, ABC-AHP-NCNPR Botanical Adulterants Program Contact: stefan@herbalgram.org

More information

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines International Conference organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council

More information

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS Berberis vulgaris ad praeparationes homoeopathicas Other Latin name used in homoeopathy : Berberis DEFINITION

More information

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS Artemisia absinthium ad praeparationes homoeopathicas Other Latin name used in homoeopathy: Artemisia absinthium DEFINITION

More information

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of

More information

LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS

LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS Lavandula angustifolia ad praeparationes homoeopathicas DEFINITION Fresh, blooming, flower-heads of Lavandula angustifolia

More information

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS Nerium oleander ad praeparationes homoeopathicas Other Latin name used in homeopathy: Oleander DEFINITION Fresh leaf

More information

Topics covered by the talk

Topics covered by the talk 04/02/2016 Finished product monographs containing chemically defined active substances Dr Dirk Leutner Scientific Officer, European Pharmacopoeia Department European Directorate for the Quality of Medicines

More information

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS Coccus cacti ad praeparationes homoeopathicas DEFINITION Whole, dried, female insect, Coccus cacti L. (Dactylopius coccus

More information

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia February 2012 ARTENIMOLUM ARTENIMOL Adopted revised text for addition to The International Pharmacopoeia This monograph was adopted at the Forty-sixth WHO Expert Committee on Specifications for Pharmaceutical

More information

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS Artemisia absinthium ad praeparationes homoeopathicas Other Latin name used in homoeopathy: Artemisia absinthium DEFINITION

More information

Guide. homoeopathic preparations. for the elaboration of monographs on

Guide. homoeopathic preparations. for the elaboration of monographs on Guide for the elaboration of monographs on homoeopathic preparations " Stocks for homoeopathic preparations may be of mineral, chemical, botanical, zoological or human origin European Pharmacopoeia Homoeopathic

More information

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010) August 2010 RESTRICTED REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM (August 2010) DRAFT FOR COMMENT This document was provided by a quality control expert

More information

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010) August 2010 RESTRICTED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010) DRAFT FOR COMMENT This document was provided by a quality control expert and was

More information

How to give life? Organ donation, Let's talk about it! With the EDQM, Council of Europe. European Day for Organ Donation and transplantation (EODD)

How to give life? Organ donation, Let's talk about it! With the EDQM, Council of Europe. European Day for Organ Donation and transplantation (EODD) How to give life? Organ donation, Let's talk about it! With the EDQM, Council of Europe European Day for Organ Donation and transplantation (EODD) Organ donation How does the Council of Europe contribute?

More information

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT January 2012 RESTRICTED DRAFT PROPOSAL FOR The International Pharmacopoeia LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS (January 2012) DRAFT FOR COMMENT This document was provided by a quality control expert.

More information

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS RESTRICTED INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS DRAFT FOR COMMENT Please address any comments you may have on this document, by 12 July 2006, to Dr S. Kopp, Quality Assurance and

More information

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012) July 2012 RESTRICTED PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012) PROPOSED REVISION FOR COMMENT The background

More information

Analytical Developments for Identification and Authentication of Botanicals

Analytical Developments for Identification and Authentication of Botanicals Analytical Developments for Identification and Authentication of Botanicals James Harnly Food Composition and Methods Development Lab Beltsville Human Nutrition Research Center Agricultural Research Service

More information

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012) July 2012 RITONAVIRI COMPRESSI RITONAVIR TABLETS Final text for addition to The International Pharmacopoeia (July 2012) This monograph was adopted at the Forty-sixth WHO Expert Committee on Specifications

More information

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006) September 2006 RESTRICTED ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006) This document was provided by a contracted quality control laboratory.

More information

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS December 2009 ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS Simaba cedron ad praeparationes homoeopathicas Other Latin name used in homoeopathy: Simaruba DEFINITION Dried cotyledons

More information

Comparison of Flow Injection MS, NMR, and DNA Sequencing: Methods for Identification and Authentication of Black Cohosh (Actaea racemosa)

Comparison of Flow Injection MS, NMR, and DNA Sequencing: Methods for Identification and Authentication of Black Cohosh (Actaea racemosa) 250 Comparison of Flow Injection MS, NMR, and DNA Sequencing: Methods for Identification and Authentication of Black Cohosh (Actaea racemosa) Authors James Harnly 1, Pei Chen 1, Jianghao Sun 1, Huilian

More information

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015) August 2015 Document for comment 1 2 3 4 5 CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA (AUGUST 2015) DRAFT FOR COMMENT 6 Should you have any comments

More information

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS September 2010 RESTRICTED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS (August 2010) DRAFT FOR COMMENT This document was provided by a quality control

More information

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS December 2015 Draft document for comment 1 2 3 4 5 6 DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS (December 2015) REVISED DRAFT FOR COMMENT Should

More information

EMTRICITABINE AND TENOFOVIR TABLETS

EMTRICITABINE AND TENOFOVIR TABLETS September 2010 RESTRICTED EMTRICITABINE AND TENOFOVIR TABLETS Draft proposal for The International Pharmacopoeia (September2010) REVISED DRAFT FOR COMMENT This document was provided by a quality control

More information

Council of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes

Council of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes Counterfeiting of medical products and similar crimes involving threats to public health are a

More information

Recent Advance in Chemical and Biological Studies on Cimicifugeae Pharmaceutical Resources

Recent Advance in Chemical and Biological Studies on Cimicifugeae Pharmaceutical Resources Hao DC et al. Chinese Herbal Medicines, 2013, 5(2): 81-95 81 Reviews Recent Advance in Chemical and Biological Studies on Cimicifugeae Pharmaceutical Resources HAO Da-cheng 1*, GU Xiao-jie 1, XIAO Pei-gen

More information

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) June 2010 TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

BLACK COHOSH. Proper name(s): Actaea racemosa L. (Ranunculaceae) (USDA 2006)

BLACK COHOSH. Proper name(s): Actaea racemosa L. (Ranunculaceae) (USDA 2006) BLACK COHOSH This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications and labels for natural health product market authorization. It is not intended

More information

Council of Europe The Medicrime Convention

Council of Europe The Medicrime Convention Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes What is a counterfeit medical product? It is a product with a deliberately false representation

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution August 2015 Draft document for comment 1 2 3 4 5 6 Draft monograph for inclusion in The International Pharmacopoeia Dextromethorphani solutionum peroralum - Dextromethorphan oral solution (August 2015)

More information

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012) August 2012 RESTRICTED ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012) Draft for comment This document was provided by a quality control expert. Should you have

More information

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010) September 2010 RESTRICTED SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010) REVISED DRAFT FOR COMMENT This document was provided by a quality

More information

Assay Name: Transwell migration using DAPI

Assay Name: Transwell migration using DAPI Assay Name: Transwell migration using DAPI Assay ID: Celigo_04_0001 Table of Contents Experiment: Identification of cells which have migrated through the membrane of a transwell insert....2 Celigo Setup...2

More information

: St. John s wort dry extract HRS

: St. John s wort dry extract HRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 14/05/2014 Supersedes: 01/10/2009 Version: 4.0 SECTION 1: Identification of the substance/mixture

More information

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

Good pharmacopoeial practices: Chapter on monographs on herbal medicines Annex 7 Good pharmacopoeial practices: Chapter on monographs on herbal medicines Background Following the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations,

More information

BMC Cancer. Open Access. Abstract

BMC Cancer. Open Access. Abstract BMC Cancer BioMed Central Research article Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma Ze Tian 1,2, Jianyong Si 2,

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 01 September 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State) DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT

More information

Final text for addition to The International Pharmacopoeia (June 2010)

Final text for addition to The International Pharmacopoeia (June 2010) June 2010 KANAMYCIN ACID SULFATE: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WH Expert Committee on Specifications for Pharmaceutical

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Substance name : Substance : Salicylic acid

More information

USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements

USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements 1 USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements Roundtable s objectives Foster discussion among the participants to

More information

Ethanol extract of Cimicifugae rhizoma exerted more potent antiinflammatory and tumor suppressor activities compared with methanol and water extracts.

Ethanol extract of Cimicifugae rhizoma exerted more potent antiinflammatory and tumor suppressor activities compared with methanol and water extracts. Biomedical Research 2016; 27 (4): 1054-1059 Ethanol extract of Cimicifugae rhizoma exerted more potent antiinflammatory and tumor suppressor activities compared with methanol and water extracts. Su-Hyeon

More information

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and

More information

Public Assessment Report. Scientific discussion. Lorazepam GenRx 1 mg and 2.5 mg tablets. (lorazepam) NL/H/3485/ /DC

Public Assessment Report. Scientific discussion. Lorazepam GenRx 1 mg and 2.5 mg tablets. (lorazepam) NL/H/3485/ /DC Public Assessment Report Scientific discussion Lorazepam GenRx 1 mg and 2.5 mg tablets (lorazepam) NL/H/3485/001-002/DC Date: 13 March 2015 This module reflects the scientific discussion for the approval

More information

J Korean Soc Menopause 2012;18: ISSN J Korean Soc Menopause 2012;18:

J Korean Soc Menopause 2012;18: ISSN J Korean Soc Menopause 2012;18: ISSN 1226-8704 Original Article 폐경기여성에서승마물질의비뇨기위축과부작용에대한효과 홍성남 1 김진하 2 김흥열 2 김아리 3 성균관대학교의과대학창원삼성병원산부인과 1, 고신대학교의과대학산부인과학교실 2, 원광대학교의과대학원광의과학연구소산부인과학교실 3 Effect of Black Cohosh on Genital Atrophy and Its

More information

Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods

Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Culture Media for Compendial Methods

More information

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS Ceanothus americanus siccum ad praeparationes homoeopathicas Other Latin name used in homoeopathy

More information

Public Assessment Report Scientific discussion. Modafinil Bluefish (modafinil) SE/H/1325/01/DC

Public Assessment Report Scientific discussion. Modafinil Bluefish (modafinil) SE/H/1325/01/DC Public Assessment Report Scientific discussion Modafinil Bluefish (modafinil) SE/H/1325/01/DC This module reflects the scientific discussion for the approval of Modafinil Bluefish. The procedure was finalised

More information

Public Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG:

Public Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG: Public Assessment Report Scientific discussion Pentasa Compact 4 g, prolonged-release granules (mesalazine) NL License RVG: 114015 Date: 30 March 2015 This module reflects the scientific discussion for

More information

Public Assessment Report. Scientific discussion. Pregabalin Orion (pregabalin) SE/H/1440/01-07/DC

Public Assessment Report. Scientific discussion. Pregabalin Orion (pregabalin) SE/H/1440/01-07/DC Public Assessment Report Scientific discussion Pregabalin Orion (pregabalin) SE/H/1440/01-07/DC This module reflects the scientific discussion for the approval of Pregabalin Orion. The procedure was finalised

More information

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Public Assessment Report for a Homeopathic Medicinal Product for Human Use IPAR Public Assessment Report for a Homeopathic Medicinal Product for Human Use Teetha Teething Gel HOA1149/007/001 HOA holder: A. Nelson & Company Limited Date: 16 November 2018 16 November 2018 CRN008K7Z

More information

Public Assessment Report Scientific discussion. Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC

Public Assessment Report Scientific discussion. Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC Public Assessment Report Scientific discussion Ciprofloxacin Accord (ciprofloxacin hydrochloride) SE/H/1026/01-03/DC This module reflects the scientific discussion for the approval of Ciprofloxacin Accord.

More information

Photosensitivity of Internal Standard Valerophenone

Photosensitivity of Internal Standard Valerophenone Photosensitivity of Internal Standard Valerophenone Used in USP Ibuprofen Bulk Drug and Tablet Assay and Its Effect on the Quantitation of Ibuprofen and Its Impurities Sherri Farmer, Leslie McCauslin,

More information

AHPA Guidance Policies. Rev. 03/05/14

AHPA Guidance Policies. Rev. 03/05/14 AHPA develops guidance policies to advance our Mission to promote responsible commerce in herbal supplements. These policies address a variety of labeling and manufacturing issues and reflect the consensus

More information

quality and safety of pharmacy preparations in Europe

quality and safety of pharmacy preparations in Europe quality and safety of pharmacy preparations in Europe Henk Scheepers, Pharm D, Senior-Inspector Public Health Supervisory Service Health Care Inspectorate The Netherlands 1 Nothing to disclose 2 1 quality

More information

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013 The 7 truths of impurities and their reference standards FDA's and other regulators' viewpoints and further stories (Part 1) Dr. Christian Zeine LGC Standards GmbH Webinar Series 2013 July 2013 Quick guide

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION 1 INTRODUCTION This application has been submitted to the EMEA for the CHMP to issue a scientific opinion in accordance with Article 58 of Regulation (EC) No 726/2004, in the context

More information

Public Assessment Report Scientific discussion. Lamotrigin Medartuum Lamotrigine SE/H/728/01-04/MR

Public Assessment Report Scientific discussion. Lamotrigin Medartuum Lamotrigine SE/H/728/01-04/MR Public Assessment Report Scientific discussion Lamotrigin Medartuum Lamotrigine SE/H/728/01-04/MR This module reflects the scientific discussion for the approval of Lamotrigin Medartuum. The procedure

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 21 September 2006 EMEA/CHMP/BWP/298390/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON

More information

Media Messaging. Australian Complementary Medicines. Updated: January 2019 Complementary Medicines Australia (2019)

Media Messaging. Australian Complementary Medicines. Updated: January 2019 Complementary Medicines Australia (2019) Media Messaging Australian Complementary Medicines Updated: January 2019 Complementary Medicines Australia (2019) A Healthy Industry In Australia and globally, consumers are increasing including complementary

More information

Decentralised Procedure. Public Assessment Report. Allopurinol tablets 100 mg Allopurinol tablets 300 mg Allopurinol DE/H/ / /DC

Decentralised Procedure. Public Assessment Report. Allopurinol tablets 100 mg Allopurinol tablets 300 mg Allopurinol DE/H/ / /DC Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report Allopurinol tablets 100 mg Allopurinol tablets 300 mg Allopurinol DE/H/1354-1356/001-002/DC Applicant:

More information

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA Document No.: MCA/HMPG/17/12/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017 Version

More information

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General Concepts in the European Pharmacopoeia Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe General notices Anne-Sophie Bouin, 28/10/09 2009 EDQM, Council of Europe, All

More information

Product Guide for LudgerSep TM ur2 UHPLC Column for DMB Sialic Acid Analysis

Product Guide for LudgerSep TM ur2 UHPLC Column for DMB Sialic Acid Analysis Product Guide for LudgerSep TM ur2 UHPLC Column for DMB Sialic Acid Analysis Product # LS-UR2-2.1x100 Ludger Document # LS-uR2-DMB-Guide-v2.1 Ludger Ltd Culham Science Centre Oxford OX14 3EB United Kingdom

More information

Novel, Universal Approach for the Measurement of Natural Products in a Variety of Botanicals and Supplements, Part 2

Novel, Universal Approach for the Measurement of Natural Products in a Variety of Botanicals and Supplements, Part 2 Novel, Universal Approach for the Measurement of Natural Products in a Variety of Botanicals and Supplements, Part 2 Ian N. Acworth, 1 Bruce A. Bailey, 1 Marc Plante, 1 Qi Zhang, 1 David Thomas, 1 and

More information

Product Guide for LudgerSep TM R1 HPLC Column for DMB labelled Sialic Acid Analysis

Product Guide for LudgerSep TM R1 HPLC Column for DMB labelled Sialic Acid Analysis Product Guide for LudgerSep TM R1 HPLC Column for DMB labelled Sialic Acid Analysis Product # LS-R1-4.6x150 Ludger Document # LS-R1-DMB-Guide-v5.1 Ludger Ltd Culham Science Centre Oxford OX14 3EB United

More information

7-012: Detection of Alternaria padwickii on Oryza sativa (Rice)

7-012: Detection of Alternaria padwickii on Oryza sativa (Rice) International Rules for Seed Testing Annexe to Chapter 7: Seed Health Testing Methods Published by: International Seed Testing Association (ISTA), Bassersdorf, Switzerland 2014 DISCLAIMER: whilst ISTA

More information

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016) August 2016 Draft for comments 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS)

More information

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic. Browse: British Pharmacopoeia 2013 British Pharmacopoeia Volume I & II Monographs: Medicinal and Pharmaceutical Substances Methotrexate Methotrexate General Notices (Ph. Eur. monograph 0560) C 20 H 22

More information

Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride)

Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride) Public Assessment Report Scientific discussion Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride) Asp. no: 2006-1626 - 1628 This module reflects the scientific discussion for the approval of Ciprofloxacin

More information

Regulation of FMD vaccines within the European Union

Regulation of FMD vaccines within the European Union Introduction Regulation of FMD vaccines within the European Union K De Clercq 1 and D K J Mackay 2 Appendix 36 The EUFMD European Pharmacopoeia Working Group made a proposal for revision of the FMD vaccine

More information

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use Frequently Asked Questions Q4B: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions The Q4B Expert Working Group developed a set of frequently asked questions to help users

More information

VarseoWax CAD/Cast GEBRAUCHSANWEISUNG INSTRUCTIONS FOR USE MODE D EMPLOI INSTRUCCIONES DE USO ISTRUZIONI PER L USO Partners in Progress

VarseoWax CAD/Cast GEBRAUCHSANWEISUNG INSTRUCTIONS FOR USE MODE D EMPLOI INSTRUCCIONES DE USO ISTRUZIONI PER L USO Partners in Progress www.bego.com VarseoWax CAD/Cast GEBRAUCHSANWEISUNG INSTRUCTIONS FOR USE MODE D EMPLOI INSTRUCCIONES DE USO ISTRUZIONI PER L USO Partners in Progress EN INSTRUCTION FOR USE VarseoWax CAD/Cast VarseoWax

More information

CLINDAMYCIN PALMITATE

CLINDAMYCIN PALMITATE February 2018 Document for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 CLINDAMYCIN PALMITATE POWDER FOR ORAL

More information

HARMONISED PHARMACOPOEIA DEHYDRATED CULTURE MEDIA FOR SUPPORTING REGULATORY COMPLIANCE AVAILABLE NOW P O RTF O LIO.

HARMONISED PHARMACOPOEIA DEHYDRATED CULTURE MEDIA FOR SUPPORTING REGULATORY COMPLIANCE AVAILABLE NOW P O RTF O LIO. DEHYDRATED CULTURE MEDIA FOR ENHANCED P O RTF O LIO AVAILABLE NOW HARMONISED PHARMACOPOEIA SUPPORTING REGULATORY COMPLIANCE A Neogen Company THE GATEWAY TO MICROBIOLOGY INTRODUCTION Harmonised Pharmacopoeia;

More information

drneu.op an Dn.toEte for the

drneu.op an Dn.toEte for the COUNCIL OT EUROPE drneu.op an Dn.toEte for the Quality of Mediciner & Healthcare CONSTII DE feurope Certification of Substances Division Certifi cate of suitability No. RI-CEP 2OO6-227-Rev OO 1 Name of

More information

Public Assessment Report Scientific discussion. Eezeneo (Diclofenac potassium) Asp. no:

Public Assessment Report Scientific discussion. Eezeneo (Diclofenac potassium) Asp. no: Public Assessment Report Scientific discussion Eezeneo (Diclofenac potassium) Asp. no: 2005-0629 - 2005-0630 This module reflects the scientific discussion for the approval of Eezeneo. The procedure was

More information

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 93 Carbon Black, Titanium Dioxide, and Talc LYON, FRANCE 2010

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS DISCUSSION IN THE SUBGROUP STABILITY April / May 2008 DISCUSSION

More information

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012) August 2012 RESTRICTED CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012) Draft for comment This document was provided by a quality control expert. Should you have any comments

More information

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008) August 2008 RESTRICTED MEBENDAZOLE Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008) REVISED DRAFT FOR ADOPTION This document was provided by a quality control

More information

General concepts in the Ph. Eur.: theory and rationale

General concepts in the Ph. Eur.: theory and rationale General concepts in the Ph. Eur.: theory and rationale Cathie VIELLE Head of European Pharmacopoeia Department, EDQM / CoE 1 The structure of the Ph. Eur. General monographs Dosage form monographs General

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Forthyron

More information

RayBio DPP4 Inhibitor Screening Kit

RayBio DPP4 Inhibitor Screening Kit RayBio DPP4 Inhibitor Screening Kit User Manual Version 1.0 Mar 25, 2013 RayBio DPP4 Inhibitor Screening (Cat#: 68SR-DPP4-S100) RayBiotech, Inc. We Provide You With Excellent Support And Service Tel:(Toll

More information

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS Arnica montana ad praeparationes homoeopathicas DEFINITION Whole, fresh, blooming plant Arnica montana L.

More information

: Magnesium aspartate dihydrate CRS

: Magnesium aspartate dihydrate CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 13/05/2014 Supersedes: 25/11/2009 Version: 7.0 SECTION 1: Identification of the substance/mixture

More information

Supplementary Figure 1. Rab27a-KD inhibits speed and persistence of HEp3 cells migrating in the chick CAM. (a) Western blot analysis of Rab27a

Supplementary Figure 1. Rab27a-KD inhibits speed and persistence of HEp3 cells migrating in the chick CAM. (a) Western blot analysis of Rab27a Supplementary Figure 1. Rab27a-KD inhibits speed and persistence of HEp3 cells migrating in the chick CAM. (a) Western blot analysis of Rab27a expression in GFP-expressing HEp3 cells. (b) Representative

More information

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15 vii LIST OF TABLES TABLE NO DESCRIPTION PAGE CHAPTER- 1 1.1 System Suitability Parameters and Recommendations 07 1.2 Acidic and Alkaline Hydrolysis 15 1.3 Oxidative Degradation Study 16 1.4 Hydrolysis

More information

State Pharmacopoeia of Ukraine

State Pharmacopoeia of Ukraine State Pharmacopoeia of Ukraine WHO INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29.02 2.03 2012 Geneva, Executive Board Room Oleksandr Gryzodub Director of «Ukrainian Scientific Pharmacopoeial Center

More information

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.:

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.: Läkemedelsverket 2014-04-15 Public Assessment Report Scientific discussion Ginsana, oral solution (Panax ginseng C.A. Meyer, radix, standardised dry extract G115 Pharmaton (0.9-3.9:1, 40% ethanol)) Asp.no.:

More information